JPRN-jRCT1080224511招募中2 期
Clinical trial to examine the effectiveness of AMPA-PET to identify epileptogenic focus in refractory epilepsy patients
Tomoyuki Miyazaki (Coordinating Investigator)0 个研究点目标入组 40 人开始时间: 2019年1月10日最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 ot applicable（—）
- 性别
- All
入选标准
- •(1)refractory epilepsy patients
- •(2)patients who are planned to undergo lesionectomy
- •(3)patients who are without cerebral surgery
- •(4)patients who are 20 years or older
- •(5)patients who can consent to this study by oneself
排除标准
- •(1)patients who have experienced the electric stimulation therapy
- •(2)patients who have severe kidney dysfunction within 7 days before 1st registration
- •(3)patients who have severe liver dysfunction within 7 days before 1st registration
- •(4)patients who should avoid from taking MRI or PET examination
- •(5)breast-feeding mothers, expecting mothers, females who desire to be a mother
- •(6)patients who desire to bear a child within this study period
- •(7)patients who take Fycompa or Topiramate within 4 weeks before 1st registration
- •(8)Patients who are suspected of severe alcohol sensitivity
- •(9)patients who have tumor suspected to be epileptogenic before 1st registration
- •(10)patients who underwent unapproved nuclear medicine examination within 24 weeks before 1st registration
- •(11)patients who underwent other clinical trials within 12 weeks before 1st registration
- •(12)patients who have uncontrollable diabetes
- •(13)patients whom study doctors consider unappropriated
研究者
相似试验
进行中（未招募）
3 期
Which antibiotic is better to prevent meningitis after head injury: Ampicillin or Ceftriaxone?CTRI/2013/07/003831Gopalakrishnan MS
进行中（未招募）
1 期
The purpose of this study is to assess the good and bad effects (efficacy and safety) of apixaban compared with usual care anticoagulation in people with Atrial Fibrillation in whom an early cardioversion is planned.EUCTR2014-001231-36-DEBristol-Myers Squibb International Corporation1,500
进行中（未招募）
1 期
The purpose of this study is to assess the good and bad effects (efficacy and safety) of apixaban compared with usual care anticoagulation in people with Atrial Fibrillation in whom an early cardioversion is planned.on-Valvular Atrial Fibrillation in patients undergoing CardioversionMedDRA version: 19.0Level: PTClassification code 10003658Term: Atrial fibrillationSystem Organ Class: 10007541 - Cardiac disordersEUCTR2014-001231-36-BEBristol-Myers Squibb International Corporation1,500
进行中（未招募）
1 期
The purpose of this study is to assess the good and bad effects (efficacy and safety) of apixaban compared with usual care anticoagulation in people with Atrial Fibrillation in whom an early cardioversion is planned.on-Valvular Atrial Fibrillation (AF) in patients undergoing CardioversionMedDRA version: 17.0Level: PTClassification code 10003658Term: Atrial fibrillationSystem Organ Class: 10007541 - Cardiac disordersEUCTR2014-001231-36-ESBristol-Myers Squibb International Corporation1,500
进行中（未招募）
1 期
The purpose of this study is to assess the good and bad effects (efficacy and safety) of apixaban compared with usual care anticoagulation in people with Atrial Fibrillation in whom an early cardioversion is planned.EUCTR2014-001231-36-DKBristol-Myers Squibb International Corporation1,500